And Progen is of course carrying out much of its testing in US hospitals. Perhaps both the patients and the research medical staff are starting to see some interesting and encouraging results. And then deciding to have an interest in a stock that is very much unsung including by its own management.
up 43% with large volume on nasdaq, page-2
Add PGL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.46M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 44.0¢ | 44.0¢ | $14.12K | 32.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 773989 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 37049 | 4 |
View Market Depth
| Last trade - 13.26pm 10/07/2024 (20 minute delay) ? |
| PGL (ASX) Chart |